BofA analyst Brad Sills lowered the firm’s price target on DocuSign to $65 from $80 and keeps a Neutral rating on the shares following the company’s Q3 report. DocuSign reported "healthy" billings upside from early traction with new go to market initiatives, though it gave "a macro tempered preliminary outlook for FY24," Sills tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DOCU:
- DocuSign upgraded to Neutral from Underweight at Piper Sandler
- DocuSign Stock Soars 8% on Earnings and Revenue Beat
- DocuSign reports Q3 adjusted gross margin 83% vs. 82% last year
- DocuSign Announces Third Quarter Fiscal 2023 Financial Results
- DocuSign sees FY23 revenue $2.493B-$2.497B, consensus $2.49B